Seoul Asan Medical Center Analyzes 1,677 Cases
Colorectal Cancer Sensitivity at 90.4%, Stages 1–4 Sensitivity from 84.2% to 100%
Detection Rate for Advanced Colorectal Polyps Also at 58.3%

Seoul Asan Medical Center announced on August 27 that the research team, led by Professors Jeongsik Byun and Seungwook Hong of the Department of Gastroenterology, has confirmed the potential of a blood test method that diagnoses colorectal cancer by analyzing cell-free DNA (cfDNA) in the blood using artificial intelligence (AI).

A graphic illustrating a cell-free DNA blood diagnostic method that can diagnose colorectal cancer using only blood tests through artificial intelligence (AI). Seoul Asan Medical Center

A graphic illustrating a cell-free DNA blood diagnostic method that can diagnose colorectal cancer using only blood tests through artificial intelligence (AI). Seoul Asan Medical Center

View original image

The research team, in collaboration with GC Genome, a company specializing in liquid biopsy and clinical genome analysis, analyzed the blood of a total of 1,677 individuals, including 302 colorectal cancer patients, 108 patients with advanced colorectal polyps, and 1,267 healthy controls. After extracting cell-free DNA from the blood samples and analyzing it with next-generation sequencing (NGS), data such as DNA fragment length, terminal structure, and genomic distribution were applied to an AI deep learning model.


As a result, the sensitivity of colorectal cancer diagnosis was found to be 90.4%, and the specificity in the healthy control group was 94.7%. Sensitivities by cancer stage were 84.2% for stage 1, 85.0% for stage 2, 94.4% for stage 3, and 100% for stage 4. Early-stage colorectal cancer, which can be treated endoscopically, was detected with a sensitivity of 90%. The sensitivity for advanced colorectal polyps, a precancerous state, was confirmed to be 58.3%.


Currently, the national colorectal cancer screening primarily uses the fecal occult blood test, and if the result is positive, a colonoscopy is performed. The research team expects that utilizing blood tests could reduce the burden of stool collection and bowel preparation required for colonoscopy, improving access to screening.



Professor Jeongsik Byun stated, "We have presented the potential to reduce the burden of current screening methods and to screen for colorectal cancer using only a blood test. The combination of the convenience of blood-based diagnosis and AI technology is expected to enable more accessible colorectal cancer screening." The research results were recently published in the international journal American Journal of Gastroenterology.

From the left, Jeongsik Byun and Seunguk Hong, Professors of Gastroenterology at Asan Medical Center, Seoul. Asan Medical Center, Seoul

From the left, Jeongsik Byun and Seunguk Hong, Professors of Gastroenterology at Asan Medical Center, Seoul. Asan Medical Center, Seoul

View original image


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing